top of page
Search

Salesforce (CRM)

Writer: Abacus Research
Abacus Research
Oct 31, 2024
1 min read

Salesforce is another potential convert to ‘AI beneficiary’, plus there are reasons to be positive on continued margin expansion.

  • The business has the potential to see both better revenue growth as well as expanding operating margins with a share price that is discounting neither.

  • If CRM can apply AgentForce to its own sales process, and there is a high ROI, then street ests look conservative to us.


Potential Upside:     $375 (+25%)

Sensible Downside: $270 (-10%)


 
 
 

Recent Posts

See All
GOOGL, AMZN: Plays on inference and bundling

We see the power moving back towards the Hyperscalers, and find the combination of less risk, high growth and reasonable valuations to be compelling. AMZN: sensible upside to $305 (+20%) SOTP model an

 
 
 
RYAN / Insurance Cycle

Ryan (RYAN) is a typical hard market beneficiary, that is going through an organic growth reset. Are we there yet in terms of the reset- probably not. Timing the bottom of a cyclical market is hard. N

 
 
 

Comments

bottom of page